He Hai Yu . The Expression of GP73 in Serum and Tissues of Patients with Chronic Hepatitis B,Liver Cirrhosis and Primary Live r Cancer[J]. Journal of Kunming Medical University, 2016, 37(04).
Citation: He Hai Yu . The Expression of GP73 in Serum and Tissues of Patients with Chronic Hepatitis B,Liver Cirrhosis and Primary Live r Cancer[J]. Journal of Kunming Medical University, 2016, 37(04).

The Expression of GP73 in Serum and Tissues of Patients with Chronic Hepatitis B,Liver Cirrhosis and Primary Live r Cancer

  • [Abstract]Objective To study the expression of GP73 in the serum and tissue of patients with chronic hepatitis B, liver cirrhosis and primary liver cancer. Methods(1)Double-antibody sandwich ELISA was used to test the level of GP 73 in serum and tissue of of patients with chronic hepatitis B, liver cirrhosis and primary liver cancer and normal control group. 2. Immunohistochemical SP methods were used to test the level of GP 73 in serum and tissue of of patients with chronic hepatitis B, liver cirrhosis and primary liver cancer and normal control group. Results The expression of GP73 in the serum and tissue was irrelevant to sex and age. The expression levels of GP73 were increasing gradually in the patients with chronic hepatitis B and liver cirrhosis . GP73 was relevant to the progression of Chronic hepatitis B. The concentration of GP73 in the serum and tissue of the patients with chronic hepatitis B was relevant to AFP,HBV-DNA,and had a significant correlation with ALP.Conclusion The expression of GP73 seems closely related to the occurrence and progression of hepatocarcinoma, which will be useful in the diagnosis and prognostic evaluation of hepatocarcinoma and in the conjecture of hepatic neoplasm and identification of Malignant Diseases,and will be a valuable marker of hepatocarcinoma.
  • loading
  • Relative Articles

    [1] Qiong WU, Na LI, Yujuan XU. Visual Analysis of Symptom Clusters of Hepatocarcinoma Patients Based on Citespace. Journal of Kunming Medical University, 2024, 45(11): 59-66.  doi: 10.12259/j.issn.2095-610X.S20241109
    [2] Hongyan WEI, Yuanzhen WANG, Lixian CHANG, Huan MU, Chunyun LIU, Li LIU. Risk Prediction of SBP in Patients with Primary Liver Cancer Complicated with Ascites. Journal of Kunming Medical University, 2024, 45(3): 133-140.  doi: 10.12259/j.issn.2095-610X.S20240320
    [3] Xuesha ZHANG, Jie ZHOU, Cailin LI, Dingyu WU, Fang PENG. Effects of Periplaneta americana Extract on Autophagy and Invasive Metastasis of Subcutaneous Transplanted Hepatocellular Carcinoma in Nude Mice. Journal of Kunming Medical University, 2023, 44(10): 39-46.  doi: 10.12259/j.issn.2095-610X.S20231018
    [4] Liqiang LAN, Jing LI, Qingbo REN. Value Evaluation of New Markers AFP-L3 and PIVKAⅡ in the Diagnosis of Liver Cancer. Journal of Kunming Medical University, 2023, 44(7): 136-141.  doi: 10.12259/j.issn.2095-610X.S20230705
    [5] Xiaohua LU, Hongxin YUAN. The Analysis of the Correlation between BTLA,CTLA-4 Gene Polymorphisms and the Efficacy and Prognosis of TACE Combined Targeted Therapy for Liver Cancer. Journal of Kunming Medical University, 2023, 44(9): 126-135.  doi: 10.12259/j.issn.2095-610X.S20230927
    [6] Xi GUO, Xiaoqing TANG, Jie WANG, Yan WAN, Bin XU, Yu LUO. Effect of Early Interventional Palliative Treatment on Pain and Anxiety in Patients with Hepatitis-Related Liver Cancer. Journal of Kunming Medical University, 2022, 43(8): 93-99.  doi: 10.12259/j.issn.2095-610X.S20220813
    [7] Heng ZHANG, Cheng ZHANG, Weiran LIAO, Yutao HE, Yuyang ZHANG, Bin DU, Lin WANG. Research Progress of Zinc Finger Protein and Hepatocellular Carcinoma. Journal of Kunming Medical University, 2022, 43(1): 144-149.  doi: 10.12259/j.issn.2095-610X.S20220135
    [8] Song-xu QI, Cheng QIU, Rong-jun CHEN, Zhan-hui CHEN, Wan-yu ZHANG, Shi-long TANG, Fan CAO, Chun-man LI, Nan XIE. Expression of XB130 in Hepatocellular Carcinoma and Its Effect on Cell Invasion and Migration. Journal of Kunming Medical University, 2021, 42(4): 67-72.  doi: 10.12259/j.issn.2095-610X.S20210413
    [9] Ran Xiao Ming , Song Rui Peng , Sun Dan . . Journal of Kunming Medical University, 2020, 41(05): 85-90.
    [10] Li-xian YUAN, Hong-tao ZHANG, Rui LI, Kun-rui CHEN, Kun-qian CHEN, An-shu XU. Diagnostic Efficacy of Serum PIVKA-Ⅱ Detection in Primary Hepatocellular Carcinoma. Journal of Kunming Medical University, 2020, 41(12): 80-84.  doi: 10.12259/j.issn.2095-610X.S20201223
    [11] Zhu Rong Song , Wei Xiao Ping , Dai Bin , Fan Hai Jun , Tan Yi Zheng , Fan Xue Rong , Tian Da Guang . . Journal of Kunming Medical University, 2019, 40(05): 68-72.
    [12] Xie Qing Yun , Lei Ze Hua , Gao Feng Wei , Jiang Kang Yi . . Journal of Kunming Medical University, 2018, 39(10): 101-104.
    [13] Wu Gang . HBx Suppresses miR-338 Expression in Hepatoma via DNA Hypermethylation. Journal of Kunming Medical University, 2017, 38(11): 5-8.
    [14] Wang Jing . In Vitro Anticancer Effect of AMH-T. Journal of Kunming Medical University,
    [15] Liu Xing . Research Advance in the Role of Toll-like Receptors in Hepatocarcinogenesis. Journal of Kunming Medical University,
    [16] He Zhi Jiang . . Journal of Kunming Medical University,
    [17] Li Xiao Ning . . Journal of Kunming Medical University,
    [18] Guo Tao . . Journal of Kunming Medical University,
    [19] Liu Li Xin . . Journal of Kunming Medical University,
    [20] Yuan Hui . . Journal of Kunming Medical University,
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (2672) PDF downloads(190) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return